# Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment

> **NCT03527069** · PHASE3 · COMPLETED · sponsor: **EMS** · enrollment: 146 (actual)

## Conditions studied

- Hypertriglyceridemia
- Dyslipidemia

## Interventions

- **DRUG:** Cipros 10 association
- **DRUG:** Crestor 10 mg

## Key facts

- **NCT ID:** NCT03527069
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-29
- **Primary completion:** 2024-08-30
- **Final completion:** 2025-07-25
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03527069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03527069, "Efficacy and Safety of Cipros 10 Association on the Isolated Hypertriglyceridemia and Dyslipidemia Treatment". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT03527069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*